Investigating the Efficacy of Telemonitoring on Clinical Outcomes of Patients Aged 50 Years and Older treated with Warfarin in Hospital Affiliated to Shahid Beheshti University of Medical Sciences in 2021
Not Applicable
Recruiting
- Conditions
- T45.61Patients Aged 50 Years and Older treated with Warfarin.Poisoning by, adverse effect of and underdosing of thrombolytic drugs
- Registration Number
- IRCT20210201050208N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Patients need long-term treatment with warfarin.
Patients who do not intend to have pre-planned surgery during the study.
Exclusion Criteria
Patients who have been treated with warfarin before hospitalization or before admission and whose INR values have been within the target range for the past three months
Patients suffering from chronic diseases in acute stages such as: cancer malignancies, liver cirrhosis, respiratory failure
Patients who are unable to follow the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prothrombin Time and International Normalized Ratio (PT/INR). Timepoint: Baseline and then at intervals required. Method of measurement: blood test.;Patient readmission rate. Timepoint: After the intervention. Method of measurement: Number of hospitalizations after discharge.;Side effects of warfarin use. Timepoint: After the intervention. Method of measurement: The HAS-BLED Score.
- Secondary Outcome Measures
Name Time Method